These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2545578

  • 1. [Inhibitory effect of N-alpha-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (MK-0521) on angiotensin converting enzyme in vitro].
    Ino Y, Oda M, Sato T, Iwaki M.
    Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):219-24. PubMed ID: 2545578
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
    Oda M, Ino Y, Suzuki K, Sato T, Iwamoto S, Iwaki M.
    Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):225-34. PubMed ID: 2545579
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.
    Sybertz EJ, Baum T, Ahn HS, Nelson S, Eynon E, Desiderio DM, Pula K, Becker F, Sabin C, Moran R, Vander Vliet G, Kastner B, Smith E.
    J Cardiovasc Pharmacol; 1983 Apr; 5(4):643-54. PubMed ID: 6193364
    [Abstract] [Full Text] [Related]

  • 7. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D, Santos RA, Etelvino GM, Xavier CH, de Almeida Santos J, Mendes EP, Machado LT, Prezoto BC, Dive V, de Camargo AC.
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
    Gubert S, Braso MA, Sacristán A, Ortiz JA.
    Farmaco; 1990 Jan; 45(1):59-79. PubMed ID: 2186741
    [Abstract] [Full Text] [Related]

  • 9. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS, Arbegast PT, Gaul SL, Blaine EH, Gross DM.
    Eur J Pharmacol; 1981 Dec 03; 76(2-3):167-76. PubMed ID: 6174351
    [Abstract] [Full Text] [Related]

  • 10. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
    Hiwada K, Inoue Y, Kokubu T.
    Gen Pharmacol; 1990 Dec 03; 21(4):555-8. PubMed ID: 2165961
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of angiotensin converting enzyme by (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5-tetra- hydro-1,5-benzothiazepine-6-acetic acid (CV-5975), a non-sulfhydryl compound.
    Inada Y, Tanabe M, Itoh K, Sugihara H, Nishikawa K.
    Jpn J Pharmacol; 1988 Nov 03; 48(3):323-30. PubMed ID: 2851678
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological action of (-)-(2S,3aR,7aS)-1-[(S)-N-[(S)-1-carbonyl-3- phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid (trandolaprilat) in isolated smooth muscle preparations.
    Sekiguchi N, Ishii Y, Fujikura H, Hasegawa Y, Takayanagi I.
    Gen Pharmacol; 1993 May 03; 24(3):585-90. PubMed ID: 8396059
    [Abstract] [Full Text] [Related]

  • 13. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions.
    Brooks RR, Miller KE, Jones SM, Burns RH, Huang CT.
    J Pharm Sci; 1990 May 03; 79(5):384-8. PubMed ID: 2161922
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities.
    Kubo M, Kato J, Ochiai T, Ishida R.
    Jpn J Pharmacol; 1990 Jun 03; 53(2):201-10. PubMed ID: 2200918
    [Abstract] [Full Text] [Related]

  • 15. Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.
    Natoff IL, Nixon JS, Francis RJ, Klevans LR, Brewster M, Budd J, Patel AT, Wenger J, Worth E.
    J Cardiovasc Pharmacol; 1985 Jun 03; 7(3):569-80. PubMed ID: 2410692
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG, Rao NM.
    Indian J Biochem Biophys; 1997 Dec 03; 34(6):524-8. PubMed ID: 9594434
    [Abstract] [Full Text] [Related]

  • 17. New aspects on inflammatory reactions and cough following inhibiton of angiotensin converting enzyme.
    Lindgren BR.
    Acta Physiol Scand Suppl; 1988 Dec 03; 573():1-60. PubMed ID: 2466391
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS.
    Fed Proc; 1983 Feb 03; 42(2):167-70. PubMed ID: 6295819
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.
    Bull HG, Thornberry NA, Cordes MH, Patchett AA, Cordes EH.
    J Biol Chem; 1985 Mar 10; 260(5):2952-62. PubMed ID: 2982845
    [Abstract] [Full Text] [Related]

  • 20. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW, Wang FL, Fung WC, Grover GJ, Harvey CM, Scalese RJ, Mitch SL, DeForrest JM.
    Br J Clin Pharmacol; 1989 Mar 10; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.